It had to be done!!VRUS has a strategic collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the development of RG7128, and PSI-6130 and its prodrugs.
To bad Roche..can't have everything..
Fools rush in where angels fear to tread...GILD paid way, way too much for this company...they will be writing off the goodwill for years to come.This was a sad and desperate move by mgt and the board. Shareholders will eventually pay, as usual...
Especially when FDA pulled AVASTIN for breast cancer. GENENTECH/ROCHE where looking for another option for their playbook..GOOD JOB GILEAD!!
Avastin for breast cancer was not yet in the numbers.Prostate made the drug.